3D Global Biotech Inc. (6808.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$30.85 (+1.15%) as of
Key statistics
- Market cap
- 2.37B
- P/E (TTM)
- 171.39
- EPS (TTM)
- 0.18
- Dividend yield
- 0.43%
- 52-week range
- 22.45 – 51.50
- Beta
- 0.08
- Revenue (TTM)
- 159.19M
- Profit margin
- 8.92%
- Volume
- 54.00k
About 3D Global Biotech Inc.
3D Global Biotech Inc. manufactures and sells medical devices for human body reconstruction. It offers artificial bone grafting; 3D bioForming; bio-dressing; 3D bioture EX; 3D printing equipment, such as 3D BioRealizer system; orthodontic aligner system under the SmileAlign name; and iMatrix, a sectional matrix kit. The company was founded in 2014 and is based in New Taipei City, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- New Taipei City, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.